Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients with DM1 younger than 40 years of age and up to 35% of all persons with DM1 will die before age 55 from CVD. Strategies are needed to help identify adolescents with DM1 at risk for CVD so that interventions to prevent heart disease and stroke can be undertaken.
Patients with type 1 diabetes and healthy controls will have evaluation of their lipid profile. Arterial stiffness, heart rate variability and adiposity measurements will be done in patients with type 1 diabetes and healthy controls. Blood pressure and heart rate will be recorded. 50 ml of urine will be collected from patients and controls. All studies will be performed as a single outpatient visit at Georgetown University.
Study Type
OBSERVATIONAL
Enrollment
240
Georgetown-Howard Universities Center
Washington D.C., District of Columbia, United States
RECRUITINGsmall LDL particles
Blood test, based on NMR
Time frame: This is an observational cross sectional study. Samples will be collected through study completion, on average of 6 years duration.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.